Drug intelligence / Profile preview

Premasol

Development stage
Unknown
Lead developer
Takeda
Modality
Small Molecules
Administration
Intravenous
01

Overview

Premasol is a sterile, nonpyrogenic solution of essential and nonessential amino acids specifically designed for neonates and infants requiring parenteral nutrition. It serves as a nitrogen source to promote protein synthesis and wound healing, and to reduce the rate of protein catabolism in patients where the oral or enteral route is inadequate or impossible. The formulation is tailored to meet the unique metabolic needs of premature and low-birth-weight infants, often containing higher concentrations of certain amino acids like tyrosine and histidine compared to adult formulations. It is typically administered via central or peripheral intravenous infusion as part of a total parenteral nutrition (TPN) regimen. The Women and Infants Hospital of Rhode Island has utilized Premasol in clinical trials to evaluate whether early aggressive protein intake improves growth and neurodevelopmental outcomes in very low birthweight infants.

Brand names
Premasol
Other names
Amino acid injectionNeonatal amino acid solution
02

Targets

SERPINA1 (Alpha-1-antitrypsin)

Beyond the preview

Go deeper on Premasol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Premasol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call